Previous Chapter: References
Suggested Citation: "Acronyms." Institute of Medicine. 2000. Description and Analysis of the VA National Formulary. Washington, DC: The National Academies Press. doi: 10.17226/9879.

Acronyms

AAHP

American Association of Health Plans

ACCP

American College of Clinical Pharmacy

ACEI

angiotensin-converting enzyme inhibitor

ACP

American College of Physicians

ADE

adverse drug event

ADR

adverse drug reaction

AFDC

Aid to Families with Dependent Children

AMA

American Medical Association

AHA

American Hospital Association

AMCP

Academy of Managed Care Pharmacy

AMP

average manufacturer price

APhA

American Pharmaceutical Association

ASHP

American Society of Health-System Pharmacists

AWP

average wholesale price

BCF

Basic Core Formulary

BPA

blanket purchase agreement

CCB

calcium channel blocker

CHAMPUS

Civilian Health and Medical Programs of the Uniformed Services

CMOP

consolidated mail outpatient pharmacy

COPD

chronic obstructive pulmonary disease

COX-2

cyclooxygenase-2

Suggested Citation: "Acronyms." Institute of Medicine. 2000. Description and Analysis of the VA National Formulary. Washington, DC: The National Academies Press. doi: 10.17226/9879.

DAV

Disabled American Veterans

DESI

drug efficacy study implementation

DOD

Department of Defense

DUR

drug utilization review

FDA

Food and Drug Administration

FSS

Federal Supply Schedule

GAO

General Accounting Office

H2R

histamine2 receptor

5-HT3

5-hydroxytryptamine

HCFA

Health Care Financing Administration

HCTZ

hydrochlorothiazide

HMG-CoA RI

hydroxymethylglutaryl-coenzyme A reductase inhibitor

HMO

health maintenance organization

ICD-9

International Classification of Diseases, Ninth Edition

IOM

Institute of Medicine

IPA

Independent practice association

IV

intravenous

JCAH, JCAHO

Joint Commission on Accreditation of Hospitals, now Joint Commission on Accreditation of Healthcare Organizations

MAP

Medical Advisory Panel

MCO

managed care organization

MTF

military treatment facility

NAC

National Acquisition Center

NCQA

National Committee for Quality Assurance

NDAA

National Defense Authorization Act

NPC

National Pharmaceutical Council

NRC

National Research Council

NSAID

nonsteroidal anti-inflammatory drug

OBRA

Omnibus Budget Reconciliation Act

OTC

over the counter

1P

FDA priority (drug)

P&T

pharmacy and therapeutics

PBM

pharmacy benefits management organization

PVA

Paralyzed Veterans of America

RFP

request for proposal

Suggested Citation: "Acronyms." Institute of Medicine. 2000. Description and Analysis of the VA National Formulary. Washington, DC: The National Academies Press. doi: 10.17226/9879.

SSA

Social Security Administration

SSI

Supplemental Security Income

SSRI

selective serotonin reuptake inhibitor

TANF

Temporary Assistance for Needy Families

UM

utilization management

USP

U.S. Pharmacopoeia

VA

Department of Veterans Affairs

VFW

Veterans of Foreign Wars

VHA

Veterans Health Administration

VISN

Veterans Integrated Service Network

VSO

veterans service organization

Suggested Citation: "Acronyms." Institute of Medicine. 2000. Description and Analysis of the VA National Formulary. Washington, DC: The National Academies Press. doi: 10.17226/9879.
This page in the original is blank.
Suggested Citation: "Acronyms." Institute of Medicine. 2000. Description and Analysis of the VA National Formulary. Washington, DC: The National Academies Press. doi: 10.17226/9879.
Page 217
Suggested Citation: "Acronyms." Institute of Medicine. 2000. Description and Analysis of the VA National Formulary. Washington, DC: The National Academies Press. doi: 10.17226/9879.
Page 218
Suggested Citation: "Acronyms." Institute of Medicine. 2000. Description and Analysis of the VA National Formulary. Washington, DC: The National Academies Press. doi: 10.17226/9879.
Page 219
Suggested Citation: "Acronyms." Institute of Medicine. 2000. Description and Analysis of the VA National Formulary. Washington, DC: The National Academies Press. doi: 10.17226/9879.
Page 220
Next Chapter: Appendix A: Interim Report of the Committee on VA Pharmacy Formulary Analysis to the Department of Veterans Affairs and the Congress of the United States
Subscribe to Email from the National Academies
Keep up with all of the activities, publications, and events by subscribing to free updates by email.